Search - tctmd.com

Displaying 201 - 220 of 418

Sort: Relevancy | Date

Presentation TCT 2022

TCT 149: Does the Involvement of Left Circumflex Coronary Artery Ostium Affect Prognosis in Patients Undergoing Percutaneous Coronary Intervention for Left Main Disease?

Presenter: Wojciech Skorupski

September 18, 2022

Presentation TCT 2022

TCT 97: Comparison of Szabo 2-stenting technique with DK-CRUSH procedures performed on reanimated swine hearts within the Visible Heart® Laboratories (VHL)

Presenter: Stefano Cangemi

September 18, 2022

Presentation TCT 2022

TCT 148: Murray Law-based Quantitative Flow Ratio for Assessment of Left Main Bifurcation derived from a Single Fluoroscopic Angiographic View as Compared to FFRCT

Presenter: Yoshinobu Onuma

September 18, 2022

Presentation TCT 2022

TCT 96: Validation of the UK-BCIS CHIP-PCI Score in a Large Single-Center Registry

Presenter: GAURAV KHANDELWAL

September 18, 2022

Presentation TCT 2022

TCT 147: Long-term Clinical Outcomes and Its Predictors Between 1- and 2-stent Strategy in Coronary Bifurcation Lesions: A Baseline Clinical and Lesion Characteristic Matched Analysis

Presenter: Joonpyo Lee

September 18, 2022

Presentation TCT 2022

TCT 145: Impact of Technique on Provisional Bifurcation Stent Outcomes in the European Bifurcation Club Left Main Coronary Trial

Presenter: Sandeep Arunothayaraj

September 18, 2022

Presentation TCT 2022

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

Presenter: Patrick Serruys

September 18, 2022

Presentation TCT 2022

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

Presenter: Omar Abdel-Razek

September 18, 2022

Presentation TCT 2022

TCT 101: Machine learning-based prediction of long-term mortality following percutaneous and surgical revascularisation in patients with complex coronary artery disease: analysis of the multicentre randomised controlled SYNTAXES trial with external…

Presenter: Patrick Serruys

September 18, 2022

Presentation

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

Presenter: Matthias Bossard

September 18, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

Presenter: Hui Ying Ang

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

Presenter: John Shulze

September 18, 2022

Presentation TCT 2022

TCT 189: The efficacy and safety of an adjunctive transcoronary pacing strategy during rotational atherectomy: The results of the Strategy to ROTAblate and PACE (ROTA-PACE) study.

Presenter: M Bilal Iqbal

September 18, 2022

Presentation TCT 2022

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Presenter: Paul Underwood

September 18, 2022

Presentation TCT 2022

TCT 187: Safety of Orbital Atherectomy in Patients With and Without Aortic Stenosis

Presenter: Karthik Vedantam

September 18, 2022

Presentation TCT 2022

TCT 186: Temporal Trends and Outcomes of Non-Orbital Atherectomy in Patients With Aortic Stenosis

Presenter: Malik Shehadeh

September 18, 2022

Advertisement

TCT 149: Does the Involvement of Left Circumflex Coronary Artery Ostium Affect Prognosis in Patients Undergoing Percutaneous Coronary Intervention for Left Main Disease?

TCT 97: Comparison of Szabo 2-stenting technique with DK-CRUSH procedures performed on reanimated swine hearts within the Visible Heart® Laboratories (VHL)

TCT 148: Murray Law-based Quantitative Flow Ratio for Assessment of Left Main Bifurcation derived from a Single Fluoroscopic Angiographic View as Compared to FFRCT

TCT 96: Validation of the UK-BCIS CHIP-PCI Score in a Large Single-Center Registry

TCT 147: Long-term Clinical Outcomes and Its Predictors Between 1- and 2-stent Strategy in Coronary Bifurcation Lesions: A Baseline Clinical and Lesion Characteristic Matched Analysis

TCT 145: Impact of Technique on Provisional Bifurcation Stent Outcomes in the European Bifurcation Club Left Main Coronary Trial

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

TCT 101: Machine learning-based prediction of long-term mortality following percutaneous and surgical revascularisation in patients with complex coronary artery disease: analysis of the multicentre randomised controlled SYNTAXES trial with external…

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

TCT 189: The efficacy and safety of an adjunctive transcoronary pacing strategy during rotational atherectomy: The results of the Strategy to ROTAblate and PACE (ROTA-PACE) study.

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

TCT 187: Safety of Orbital Atherectomy in Patients With and Without Aortic Stenosis

TCT 186: Temporal Trends and Outcomes of Non-Orbital Atherectomy in Patients With Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content